- Home
- NXTC vs GP Comparison
NXTC vs GP Comparison
Compare NXTC & GP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXTC
- GP
- Stock Information
- Founded
- NXTC 2015
- GP 2010
- Country
- NXTC United States
- GP Canada
- Employees
- NXTC N/A
- GP N/A
- Industry
- NXTC Biotechnology: Pharmaceutical Preparations
- GP Construction/Ag Equipment/Trucks
- Sector
- NXTC Health Care
- GP Consumer Discretionary
- Exchange
- NXTC Nasdaq
- GP Nasdaq
- Market Cap
- NXTC 13.9M
- GP 12.7M
- IPO Year
- NXTC 2019
- GP 2020
- Fundamental
- Price
- NXTC $0.45
- GP $0.39
- Analyst Decision
- NXTC Strong Buy
- GP Strong Buy
- Analyst Count
- NXTC 2
- GP 2
- Target Price
- NXTC $3.50
- GP $2.33
- AVG Volume (30 Days)
- NXTC 346.6K
- GP 71.8K
- Earning Date
- NXTC 07-31-2025
- GP 08-13-2025
- Dividend Yield
- NXTC N/A
- GP N/A
- EPS Growth
- NXTC N/A
- GP N/A
- EPS
- NXTC N/A
- GP N/A
- Revenue
- NXTC N/A
- GP $20,656,035.00
- Revenue This Year
- NXTC N/A
- GP N/A
- Revenue Next Year
- NXTC N/A
- GP $94.25
- P/E Ratio
- NXTC N/A
- GP N/A
- Revenue Growth
- NXTC N/A
- GP N/A
- 52 Week Low
- NXTC $0.22
- GP $0.37
- 52 Week High
- NXTC $1.82
- GP $1.90
- Technical
- Relative Strength Index (RSI)
- NXTC 44.08
- GP 37.44
- Support Level
- NXTC $0.45
- GP $0.37
- Resistance Level
- NXTC $0.49
- GP $0.41
- Average True Range (ATR)
- NXTC 0.06
- GP 0.02
- MACD
- NXTC -0.01
- GP -0.00
- Stochastic Oscillator
- NXTC 0.74
- GP 21.83
About NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.
About GP GreenPower Motor Company Inc.
GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.